ArticleOncoimmunology

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study.

Jeong-Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.